Where does NeuroNexus Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NeuroNexus Technologies, Inc. ranks #9,093 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NeuroNexus Technologies, Inc. hold?

NeuroNexus Technologies, Inc. holds 35 US utility patents granted between 2015 and 2023, spanning 9 technology areas.

What is NeuroNexus Technologies, Inc.'s Innovation Score?

NeuroNexus Technologies, Inc. has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NeuroNexus Technologies, Inc. focus on?

NeuroNexus Technologies, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 34 patents, ranking #115 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is NeuroNexus Technologies, Inc.'s patent grant rate increasing or decreasing?

NeuroNexus Technologies, Inc.'s recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for NeuroNexus Technologies, Inc.'s patents?

NeuroNexus Technologies, Inc.'s patents average 23.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NeuroNexus Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NeuroNexus Technologies, Inc.

USPTO PatentsView assignee record - 35 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neuronexus ranks #9,093 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 9 technology areas.

#9,093
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 23.3
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9093 · US Corporation #9,093 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #9,093/49,997
PHOTO-FINISH Ncsoft
CPC-NARROW A61N · 9 areas
INNOV-PAR 40.6/100
CLAIMS-DENSE 23.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ncsoft Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neuronexus’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (30%) Velocity 3.7 pts (9%) Breadth 10.6 pts (26%) Claim depth 14.0 pts (34%)

Qualcomm Incorporated · highest

85
Gustav Magenwirth & · near

41
NeuroNexus · this assignee

41
Qumulo · near

41
SDB IP Holdings · near

41
Toshiba Solutions · near

41
3D Lighting… · lowest

7

What this shows Neuronexus's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neuronexus?

Each dot is one of Neuronexus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuronexus’s own 23.3 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neuronexus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neuronexus's grants concentrate

NeuroNexus Technologies, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 97.1% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (9 grants) versus a trough of 2 in 2016. By volume, Neuronexus sits between Ncsoft Corporation and Occlutech GmbH.

Neuronexus's three-year grant acceleration

NeuroNexus Technologies, Inc. shows 5 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ncsoft

35
Neuwave Medical

35
Nidec Elesys

35
Nihon University

35
OIL States Energy…

35
Osstem Implant

35
Other LAB

35
Occlutech

35
Neuronexus ◀

35

What this shows NeuroNexus holds 35 patents at rank #9,094, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NeuroNexus

By rank, the assignees closest to #9,094 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in NeuroNexus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NeuroNexus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), NeuroNexus ranks #115 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

SDB IP Holdings, LLC 41 Gustav Magenwirth GmbH & Co. 41 Qumulo, Inc. 41 Toshiba Solutions Corporation 41

Neuronexus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NeuroNexus Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	25.7%
2016	2	5.7%
2017	7	20.0%
2018	3	8.6%
2019	4	11.4%
2020	3	8.6%
2021	2	5.7%
2022	2	5.7%
2023	3	8.6%

Which technologies does NeuroNexus Technologies, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 34

A61B - DIAGNOSIS; SURGERY; Identification 27

Y10T - Technical Subjects Covered BY Former US Classification 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 5

G03F - Photomechanical Production OF Textured OR Patterned Surfaces, e.g. FOR Printing, FOR Processing OF Semiconductor DEVICES; Materials THEREFOR; Originals THEREFOR; Apparatus Specially Adapted THEREFOR; 3

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NeuroNexus Technologies, Inc.'s patent record in context - here's where to go next.

NeuroNexus Technologies, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 97.1% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #9,093 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NeuroNexus Technologies, Inc. against Ncsoft Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.